Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oogenesis02:07

Oogenesis

71.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.0K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.7K
Ovaries01:26

Ovaries

3.1K
The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
3.1K
Ovarian Cycle01:27

Ovarian Cycle

5.0K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.0K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

7.4K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
7.4K
Cancer02:18

Cancer

55.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Ovarian Cancer Is Not: Characterizing Nonovarian Cancer Pathology in a Laparoscopy-Based Triage System.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2018
Same author

Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.

Clinical cancer research : an official journal of the American Association for Cancer Research·2018
Same author

Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy.

Therapeutic advances in medical oncology·2018
Same author

Stress effects on FosB and interleukin-8 (<i>IL8</i>)-driven ovarian cancer growth and metastasis.

The Journal of biological chemistry·2018
Same author

Stress, inflammation, and eicosanoids: an emerging perspective.

Cancer metastasis reviews·2018
Same author

Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer.

Cancer·2018

Related Experiment Video

Updated: Mar 15, 2026

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

3.3K

Ovarian cancer.

Ursula A Matulonis1, Anil K Sood2, Lesley Fallowfield3

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA.

Nature Reviews. Disease Primers
|August 26, 2016
PubMed
Summary

Ovarian cancer encompasses diverse subtypes, often diagnosed late. Research focuses on understanding platinum resistance in high-grade serous carcinoma (HGSC) and identifying high-risk individuals for prevention.

More Related Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.6K
Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

12.0K

Related Experiment Videos

Last Updated: Mar 15, 2026

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

3.3K
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.6K
Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

12.0K

Area of Science:

  • Gynecologic Oncology
  • Cancer Biology
  • Genetics

Background:

  • Ovarian cancer comprises at least five distinct histological subtypes, each with unique risk factors, origins, molecular profiles, clinical presentations, and treatment responses.
  • It is a significant global health issue, frequently diagnosed at advanced stages, lacking effective screening methods.
  • Standard initial treatment involves cytoreductive surgery and platinum-based chemotherapy, with recurrent disease managed by chemotherapy, anti-angiogenic agents, PARP inhibitors, and emerging immunotherapies.

Purpose of the Study:

  • To investigate the mechanisms of platinum resistance in ovarian cancer, particularly in high-grade serous carcinoma (HGSC).
  • To identify strategies for overcoming chemotherapy resistance in recurrent ovarian cancer.
  • To explore genetic markers and precursor lesions for early detection and prevention.

Main Methods:

  • Review of current treatment modalities for newly diagnosed and recurrent ovarian cancer.
  • Analysis of molecular compositions and clinical features of different ovarian cancer subtypes.
  • Investigation of genetic associations (e.g., BRCA1/BRCA2) and precursor lesions (e.g., serous tubal intraepithelial carcinoma).

Main Results:

  • High-grade serous carcinoma (HGSC) initially responds well to platinum-based chemotherapy but frequently develops resistance.
  • Mechanisms of platinum resistance are a critical area of research for improving patient outcomes.
  • Identification of high-risk genes (BRCA1/BRCA2) and precursor lesions offers potential for risk stratification and prevention.

Conclusions:

  • Understanding and overcoming platinum resistance is crucial for advancing ovarian cancer treatment.
  • Early detection through genetic screening and identification of precursor lesions like serous tubal intraepithelial carcinoma can improve prevention strategies.
  • Ovarian cancer heterogeneity necessitates subtype-specific research and therapeutic approaches.